Open Access. Powered by Scholars. Published by Universities.®
Endocrinology, Diabetes, and Metabolism Commons™
Open Access. Powered by Scholars. Published by Universities.®
Nutritional and Metabolic Diseases
Himmelfarb Health Sciences Library, The George Washington University
Articles 1 - 1 of 1
Full-Text Articles in Endocrinology, Diabetes, and Metabolism
Promotion Of New Diabetes Products In The District Of Columbia, Joy Eckert, Dilpan Sundaramoorthy, Alycia Hogenmiller
Promotion Of New Diabetes Products In The District Of Columbia, Joy Eckert, Dilpan Sundaramoorthy, Alycia Hogenmiller
GW Research Days 2016 - 2020
Background: Growth in pharmaceutical expenditures for diabetes outpaced growth in diabetes prevalence. Prescribers accepting gifts and meals from pharmaceutical companies have been linked with higher prescription rates and costs[1]. Pharmaceutical marketing to these prescribers and patients often promotes newer, more expensive drugs, such as the GLP-1 analogues and SGL-2 inhibitors. These two drug classes are more expensive but no more effective than metformin,[2] the recommended first-line treatment for diabetes, and the oldest and cheapest available treatment. We investigated how cost of diabetes treatment was affected by marketing practices in the District of Columbia.
Methods: The AccessRx program …